SPOTLIGHT -
Any T-cell-mediated disease benefits from therapy without affecting other inflammatory pathways
Predicting intraocular inflammation after brolucizumab injections in neovascular AMD
Week in Review - December 2, 2023
EyeCon 2023: Reducing patients' retinal burden of care
Week in Review - November 26, 2023
Systematic review suggests vitamin D deficiency doubles risk of noninfectious uveitis
Case for interdisciplinary rheumatologic–ophthalmologic collaboration to optimize patient care